VANGUARD GROUP INC - MINK THERAPEUTICS INC ownership

MINK THERAPEUTICS INC's ticker is and the CUSIP is 603693102. A total of 14 filers reported holding MINK THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
VANGUARD GROUP INC ownership history of MINK THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$257,600
-49.1%
234,182
-2.9%
0.00%
Q2 2023$506,485
+444.3%
241,183
+391.1%
0.00%
Q1 2023$93,058
-27.4%
49,1070.0%0.00%
Q4 2022$128,169
+23.2%
49,1070.0%0.00%
Q3 2022$104,000
+352.2%
49,107
+374.6%
0.00%
Q1 2022$23,000
-52.1%
10,348
-3.9%
0.00%
Q4 2021$48,00010,7710.00%
Other shareholders
MINK THERAPEUTICS INC shareholders Q2 2022
NameSharesValueWeighting ↓
ORACLE INVESTMENT MANAGEMENT INC 36,898$40,5880.01%
Covestor Ltd 1,078$10.00%
UBS OCONNOR LLC 21,590$25,2600.00%
ROYAL BANK OF CANADA 649$1,0000.00%
Allworth Financial LP 2$30.00%
VANGUARD GROUP INC 234,182$257,6000.00%
Artal Group S.A. 1,916$20.00%
CHILTON CAPITAL MANAGEMENT LLC 309$3400.00%
CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM 5,066$5,9270.00%
UBS Group AG 3,547$3,9020.00%
View complete list of MINK THERAPEUTICS INC shareholders